Trust Co. of Vermont Buys 788 Shares of CME Group Inc (CME)

Trust Co. of Vermont grew its stake in CME Group Inc (NASDAQ:CME) by 1.8% during the third quarter, HoldingsChannel reports. The firm owned 44,560 shares of the financial services provider’s stock after purchasing an additional 788 shares during the period. Trust Co. of Vermont’s holdings in CME Group were worth $7,584,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. Meeder Asset Management Inc. lifted its holdings in CME Group by 84.8% during the second quarter. Meeder Asset Management Inc. now owns 789 shares of the financial services provider’s stock worth $129,000 after acquiring an additional 362 shares during the period. Kaizen Advisory LLC lifted its holdings in CME Group by 151.9% during the second quarter. Kaizen Advisory LLC now owns 816 shares of the financial services provider’s stock worth $134,000 after acquiring an additional 492 shares during the period. Sun Life Financial INC lifted its holdings in CME Group by 267.7% during the second quarter. Sun Life Financial INC now owns 923 shares of the financial services provider’s stock worth $151,000 after acquiring an additional 672 shares during the period. Buckley Wealth Management LLC bought a new stake in CME Group during the third quarter worth $201,000. Finally, Lourd Capital LLC bought a new stake in CME Group during the third quarter worth $210,000. Institutional investors own 84.30% of the company’s stock.

In related news, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction dated Thursday, October 11th. The stock was sold at an average price of $179.86, for a total transaction of $449,650.00. Following the completion of the transaction, the chief financial officer now directly owns 32,720 shares in the company, valued at $5,885,019.20. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, President Bryan T. Durkin sold 11,509 shares of the business’s stock in a transaction dated Monday, August 6th. The stock was sold at an average price of $162.01, for a total value of $1,864,573.09. Following the transaction, the president now owns 64,862 shares of the company’s stock, valued at $10,508,292.62. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 29,188 shares of company stock valued at $4,973,607. 0.43% of the stock is owned by company insiders.



CME Group stock traded up $2.32 during midday trading on Friday, hitting $179.79. 62,567 shares of the company’s stock were exchanged, compared to its average volume of 1,574,709. CME Group Inc has a 52-week low of $132.77 and a 52-week high of $183.79. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.15. The stock has a market cap of $61.53 billion, a price-to-earnings ratio of 37.73, a PEG ratio of 3.45 and a beta of 0.64.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, October 25th. The financial services provider reported $1.45 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.42 by $0.03. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The business had revenue of $904.20 million during the quarter, compared to analysts’ expectations of $910.50 million. On average, research analysts anticipate that CME Group Inc will post 6.57 earnings per share for the current year.

Several analysts have issued reports on CME shares. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a research note on Wednesday, October 3rd. Jefferies Financial Group boosted their target price on CME Group to $203.00 and gave the company a “buy” rating in a research note on Monday, October 8th. BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, October 9th. Rosenblatt Securities started coverage on CME Group in a research note on Wednesday, September 5th. They issued a “neutral” rating and a $177.00 target price on the stock. Finally, Deutsche Bank restated a “buy” rating and issued a $192.00 target price (up from $185.00) on shares of CME Group in a research note on Thursday, October 11th. Five investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $181.38.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

See Also: Asset Allocation

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply